A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases

HIGHLIGHTS

  • who: Magdy Moussa from the Ophthalmology department, Faculty of Medicine have published the article: A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases, in the Journal: (JOURNAL)
  • what: The customized IVA injection regimen is effective in inducing long-term regression of CNV secondary to trauma, laser maculopathy, uveitis, and hereditary disorders and in improving visual function.
  • how: The study was conducted in a retina tertiary center in Egypt. The quantitative data were presented as mean standard deviations and ranges when parametric and median and inter . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?